Sfoglia per Autore
New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, endowed With both NO-like and Ca2+ Channel Antagonist Vasodilator Activities
1998-01-01 DI STILO A.; VISENTIN S.; CENA C; GASCO A. M.; ERMONDI G.; GASCO A.
Resolution of some 4-benzofurazanyl and 4-benzofuroxanyl 1,4- dihydropyridine derivatives by chiral HPLC on Whelk-O1 and some polysaccharide chiral stationary phases
1999-01-01 Visentin; S.; Amiel; P.; Gasco; A.; Bonnet; B.; Suteu; C.; Roussel; C.
NO donor and biological properties of different benzofuroxans.
1999-01-01 MEDANA C; DI STILO A; VISENTIN S; FRUTTERO R; GASCO A; GHIGO D; BOSIA A
A New Synthetic Approach to Substituted β-Carboline Systems
1999-01-01 GIUSEPPE ERMONDI; SONJA VISENTIN; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO
Synthesis and Voltage-Clamp Studies of Methyl 1,4-Dihydro-2,6-dimethyl-5-nitro-4-(benzofurazanyl)pyridine-3-carboxylate Racemates and Enantiomers and of their Benzofuroxanyl Analogues
1999-01-01 VISENTIN S; AMIEL P; FRUTTERO R; BOSCHI D; ROUSSEL C; GIUSTA L; CARBONE E; GASCO A
Time and voltage dependent facilitation of L-type Ca2+ channels induced by news and classical DHP agonists in RINm5F cells
2000-01-01 L.Giusta; L. Ferrero; V. Carabelli; S.Visentin; A. Gasco; E. Carbone
Studies on New Basic NO-Donor 1,4-Dihydropyridines
2000-01-01 D. BOSCHI; G. CARON; C. CENA; S. VISENTIN; A. DI STILO; R. FRUTTERO; A. GASCO
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists
2000-01-01 S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists
2000-01-01 SONJA VISENTIN; GIUSEPPE ERMONDI; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO
Structural Investigation of Ca2+ Antagonist Benzofurazanyl and Benzofuroxanyl 1,4-Dihydropyridines
2000-01-01 G. ERMONDI; S. VISENTIN; D. BOSCHI; R. FRUTTERO; A. GASCO
Time- and voltage-dependent facilitation of L-type Ca2+ channels induced by new and classical DHP-agonists in RINm5F
2001-01-01 Giusta L.; Carabelli V.; Visentin S.; Gasco A.; Carbone E
Nitroanilines are the reduction products of benzofuroxan system by oxyhemoglobin (HbO(2)(2+))
2001-01-01 Medana C; Visentin S; Grosa G; Fruttero R; Gasco A
Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as source of beta-carboline derivatives and some related compounds
2001-01-01 S. Visentin; G. Ermondi; D. Boschi; G. Grosa; R. Fruttero; A. Gasco
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties
2001-01-01 BOSCHI D.; G. CARON; VISENTIN S.; DI STILO A.; ROLANDO B.; FRUTTERO R.; GASCO A.
Studies on Agents with Mixed NO-Dependent and Calcium Channel Antagonistic Vasodilating Activities.
2001-01-01 C. CENA; VISENTIN S.; DI STILO A.; BOSCHI D.; FRUTTERO R.; GASCO A.
PLATELET ANTIAGGREGATORY EFFECTS AND HAEMODYNAMIC ACTIVITY OF TWO TERFUROXAN ISOMER PAIRS
2002-01-01 C. CENA; VISENTIN S.; GASCO A. L.; MARTORANA P. A.; FRUTTERO R.; GASCO A.
New analogues of Ca2+-channel activator Bay K8644
2003-01-01 S. Visentin; F. Buonsanti; M. Novara; E. Carbone; A. Gasco
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties
2004-01-01 VISENTIN S.; ROLANDO B.; DI STILO A.; FRUTTERO R.; NOVARA M.; CARBONE E.; ROUSSEL C.; VANTHUYNE N.; GASCO A.
Drug-delivery applications of carbon nanotubes: raman analysis and mapping
2009-01-01 Valentina Mussi; Sonja Visentin; Chiara Biale; Nadia Barbero; Simone Musso; Rebecca Ploeger; Guido Viscardi; Ugo Valbusa
Carbon Nanotubes for targeted drug delivery
2009-01-01 C. Biale; V. Mussi; U. Valbusa; S. Visentin; G. Viscardi; N. Barbero; N. Pedemonte; L. Galietta
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile